Cookies are used for the functionality of our web site. For more information
please see our Privacy policy or Ok thanks

Seqirus


 

 

Seqirus is part of CSL Limited (ASX:CSL). As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. Seqirus operates state-of-the-art production facilities in the US, the UK and Australia, and manufactures influenza vaccines using both egg-based and cell-based technologies. It has leading R&D capabilities, a broad portfolio of differentiated products and a commercial presence in more than 20 countries. For more information visit www.seqirus.com.